Malcolm J W Sim

9PUBLICATIONS
9CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 15, 2026
Using peptide-exchange systems to interrogate peptide-specific KIR binding to HLA Class I.

|Apr 29, 2025
Peptide-specific natural killer cell receptors.

Malcolm J W Sim, Beining Li, Eric O Long

|Jul 20, 2024
Identification and structural characterization of a mutant KRAS-G12V specific TCR restricted by HLA-A3.

Malcolm J W Sim, Ken-Ichi Hanada, Zachary Stotz

|Sep 08, 2023
Innate receptors with high specificity for HLA class I-peptide complexes.

Malcolm J W Sim, Paul Brennan, Katherine L Wahl

|May 19, 2022
T cells discriminate between groups C1 and C2 HLA-C.

Malcolm J W Sim, Zachary Stotz, Jinghua Lu

|May 29, 2020
High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D.

Malcolm J W Sim, Jinghua Lu, Matthew Spencer

Pageof 2

Frequent Collaborators

4 joint publications

Eric O Long

3 joint publications

Peter D Sun

1 joint publications

Francis Hopkins

1 joint publications

Katherine L Wahl